Adjuvant therapy after radical prostatectomy: Clinical considerations

被引:4
作者
Mitra, A. [1 ]
Khoo, V. [1 ]
机构
[1] Royal Marsden Hosp, London SW3 6JJ, England
来源
SURGICAL ONCOLOGY-OXFORD | 2009年 / 18卷 / 03期
关键词
Prostate cancer; Radiotherapy; Adjuvant; Salvage; Androgen Deprivation; Chemotherapy; PSA; POSITIVE SURGICAL MARGINS; ANDROGEN DEPRIVATION; SALVAGE RADIOTHERAPY; BIOPSY CORES; CONSERVATIVE MANAGEMENT; BIOCHEMICAL RECURRENCE; PATHOLOGICAL STAGE; CANCER; DISEASE; PROGRESSION;
D O I
10.1016/j.suronc.2009.02.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There are no standardised guidelines for the role of adjuvant radiotherapy post-prostatectomy. Evidence that may shed light into its appropriate usage is marred by the difficulty in defining adjuvant radiotherapy and failure of some studies to adequately distinguish it from salvage radiotherapy. The ability to identify which prostate cancers are likely to benefit from immediate post-operative radiotherapy would enable the judicious use of this modality and minimise the unnecessary exposure to its side-effects. This review outlines the pre- and post-surgical clinical considerations that form the discussion around the requirement for adjuvant therapy; radiotherapy, androgen deprivation therapy and chemotherapy. Principles for the use of local and systemic therapies are discussed. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:247 / 254
页数:8
相关论文
共 55 条
  • [1] 20-year outcomes following conservative management of clinically localized prostate cancer
    Albertsen, PC
    Hanley, JA
    Fine, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (17): : 2095 - 2101
  • [2] Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer
    Albertsen, PC
    Hanley, JA
    Gleason, DF
    Barry, MJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11): : 975 - 980
  • [3] Defining prostate specific antigen progression after radical prostatectomy: What is the most appropriate cut point?
    Amling, CL
    Bergstralh, EJ
    Blute, ML
    Slezak, JM
    Zincke, H
    [J]. JOURNAL OF UROLOGY, 2001, 165 (04) : 1146 - 1151
  • [4] Management of prostate-specific antigen relapse in prostate cancer: A European consensus
    Boccon-Gibod, L
    Djavan, B
    Hammerer, P
    Hoeltl, W
    Kattan, MW
    Prayer-Galetti, T
    Teillac, P
    Tunn, UW
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (04) : 382 - 390
  • [5] Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
    Bolla, M
    Collette, L
    Blank, L
    Warde, P
    Dubois, JB
    Mirimanoff, RO
    Storme, G
    Bernier, J
    Kuten, A
    Sternberg, C
    Mattelaer, J
    Torecilla, JL
    Pfeffer, JR
    Cutajar, CL
    Zurlo, A
    Pierart, M
    [J]. LANCET, 2002, 360 (9327) : 103 - 108
  • [6] Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection
    Briganti, Alberto
    Karakiewicz, Pierre I.
    Chun, Felix K. -H.
    Gallina, Andrea
    Salonia, Andrea
    Zanni, Giuseppe
    Valiquette, Luc
    Graefen, Markus
    Huland, Hartwig
    Rigatti, Patrizio
    Montorsi, Francesco
    [J]. EUROPEAN UROLOGY, 2007, 51 (06) : 1573 - 1581
  • [7] Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: Evaluation of prognostic factors and creation of a prognostic scoring system
    Buskirk, Steven J.
    Pisansky, Thomas M.
    Schild, Steven E.
    Macdonald, O. Kenneth
    Wehle, Michael J.
    Kozelsky, Timothy F.
    Collie, A. Craig
    Ferrigni, Robert G.
    Myers, Robert P.
    Prussak, Karin A.
    Heckman, Michael G.
    Crook, Julia E.
    Parkert, Alexander S.
    Igel, Todd C.
    [J]. JOURNAL OF UROLOGY, 2006, 176 (03) : 985 - 990
  • [8] RESULTS OF CONSERVATIVE MANAGEMENT OF CLINICALLY LOCALIZED PROSTATE-CANCER
    CHODAK, GW
    THISTED, RA
    GERBER, GS
    JOHANSSON, JE
    ADOLFSSON, J
    JONES, GW
    CHISHOLM, GD
    MOSKOVITZ, B
    LIVNE, PM
    WARNER, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (04) : 242 - 248
  • [9] D'Amico Anthony V, 2004, J Urol, V172, pS42, DOI 10.1097/01.ju.0000141845.99899.12
  • [10] Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era
    D'Amico, AV
    Whittington, R
    Malkowicz, SB
    Weinstein, M
    Tomaszewski, JE
    Schultz, D
    Rhude, M
    Rocha, S
    Wein, A
    Richie, JP
    [J]. JOURNAL OF UROLOGY, 2001, 166 (06) : 2185 - 2188